Navigation Links
Dr. Norman E. Rosenthal Joins Paul McCartney and David Lynch at Press Conference for Benefit Concert
Date:4/2/2009

Press conference preceding the David Lynch Foundation "Change Begins Within" benefit concert in New York to include local psychiatrist

BETHESDA, Md., April 2 /PRNewswire/ -- Dr. Norman E. Rosenthal will be among the distinguished speakers at a press conference on Friday, April 3 from noon to 1:00 pm EDT. Other speakers will include Paul McCartney, Ringo Starr, Russell Simmons and the concert sponsor, David Lynch. This news conference, which may be viewed online at http://www.davidlynchfoundation.org/, will launch the David Lynch Foundation's global initiative to teach one million at-risk youth to meditate. Funds for the initiative will be raised during the "Change Begins Within" benefit concert at Radio City Music Hall on Saturday, April 4.

Dr. Rosenthal is an internationally known psychiatrist and researcher, and medical director and CEO of Capital Clinical Research Associates in Bethesda. He will discuss his work using Transcendental Meditation (TM) for the treatment of combat-related Posttraumatic Stress Disorder (PTSD) in veterans of the conflicts in Iraq and Afghanistan, as well as for Bipolar Disorder. Dr. Rosenthal will point out, "TM's untapped potential for the multitudes or people afflicted by the pain and heartache of emotional disorders."

Dr. Rosenthal is the scientist who first described Seasonal Affective Disorder and pioneered the use of light therapy during his long career at the National Institute of Mental Health and author of Winter Blues and The Emotional Revolution.

About Capital Clinical Research Associates and the David Lynch Foundation

Capital Clinical Research Associates (CCRA) is a private clinical research center located in the North Bethesda/Rockville area in suburban Maryland. CCRA conducts research in treating mood and anxiety disorders, sleep disorders, attention deficit disorder and pain.

The David Lynch Foundation raises funds to provide students, parents and teachers Transcendental Meditation (TM) training and for independent research institutions to assess the effects of the program on creativity, intelligence, brain functioning, academic performance, ADHD and other learning disorders, anxiety, depression and substance abuse.

    Contact:
    Catherine Tuggle
    Chief Operating Office
    Capital Clinical Research Associates
    Phone: 301.770.7375
    tugglect@aol.com


'/>"/>
SOURCE Capital Clinical Research Associates
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Unnecessary Spinal Surgery Will Waste Billions of Dollars in 2009 and Patients Will Continue to Suffer Unless the Primary Cause of Most Back Pain is Treated, Says Pain Specialist Norman Marcus, M.D.
2. Satellite Healthcare Announces 2008 Norman S. Coplon Extramural Grants : Grants Foster Next-Generation Kidney Disease Researchers
3. SpongeTech(R) Delivery Systems, Inc. Clarification of Yesterdays $7,500,000 Order of Uncle Normans(TM) Pet Sponge
4. Secretary Norman Y. Mineta Joins Lung Cancer Alliance Board of Directors
5. Bad Children Can Happen to Good Parents: A Survival Manual for Parents of Difficult Children by Norman E. Hoffman, Ph.D.
6. Institute for Integrative Nutrition, Joshua Rosenthal Attract Nations Top Health, Wellness Experts
7. AAPD to Present 2008 Henry B. Betts Award to International Human Rights Disability Advocate Eric Rosenthal
8. Tomato Products Wellness Council Joins Harvard Medical School and the Culinary Institute of America to Take Part in Healthy Kitchen, Healthy Lives April 2-5, 2009
9. Eli Y. Adashi, MD, MS, FACOG, Joins Inverness Medical Innovations Board of Directors
10. Medical Device Industry Expert Matthew Jenusaitis Joins Avantis Medical Board of Directors
11. Traylor Joins LocumTenens.com as Medical Director-Psychiatry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the American ... Annual Research Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. ... including advance care planning, healthcare costs and patient and family engagement. , AIR ...
(Date:6/25/2016)... ... 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his ... David Geffen School of Medicine at UCLA. He trained in Internal Medicine at Scripps ... in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to ...
(Date:6/24/2016)... ... ... Those who have experienced traumatic events may suffer from a complex set ... drug or alcohol abuse, as a coping mechanism. To avoid this pain and suffering, ... traumatic event. , Trauma sufferers tend to feel a range of emotions, from depression, ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda Cheng, ... treatment. Dr. Cheng has extensive experience with all areas of orthodontics, including robotic ... osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... proud to recognize Dr. Barry M. Weintraub as a prominent plastic surgeon and ... women in the world, and the most handsome men, look naturally attractive. Plastic ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... SYDNEY , June 26, 2016 One of ... , has announced the formation of a new biotechnology company, Noxopharm ... raise $6m in an IPO and to list on the ASX. ... drug candidate, NOX66, ready to enter a Phase 1 clinical study ... been designed to address one of the biggest problems facing cancer ...
(Date:6/26/2016)... June 27, 2016 Jazz Pharmaceuticals plc (Nasdaq: ... under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as ... Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: CPXX ) ... Daylight Time). As previously announced on May ... definitive merger agreement under which Jazz Pharmaceuticals has commenced ...
(Date:6/26/2016)... Ontario , June 27, 2016  VMS Rehab ... Company,s Board will take whatever measures required to build ... Company,s stock which is currently listed on the OTC ... Wexler, Company Chairman and CEO, "We are seeing an ... difficult to understand, not only by the Company, but ...
Breaking Medicine Technology: